Pará Camila, Bose Poulomee, Pshezhetsky Alexey V
CHU Sainte-Justine Research Center, University of Montreal, Montreal, QC H3T 1C5, Canada.
Department of Anatomy and Cell Biology, McGill University, Montreal, QC H3A 0C7, Canada.
J Clin Med. 2020 Feb 25;9(3):616. doi: 10.3390/jcm9030616.
About two thirds of the patients affected with lysosomal storage diseases (LSD) experience neurological manifestations, such as developmental delay, seizures, or psychiatric problems. In order to develop efficient therapies, it is crucial to understand the neuropathophysiology underlying these symptoms. How exactly lysosomal storage affects biogenesis and function of neurons is still under investigation however recent research highlights a substantial role played by synaptic defects, such as alterations in synaptic spines, synaptic proteins, postsynaptic densities, and synaptic vesicles that might lead to functional impairments in synaptic transmission and neurodegeneration, finally culminating in massive neuronal death and manifestation of cognitive symptoms. Unveiling how the synaptic components are affected in neurological LSD will thus enable a better understanding of the complexity of disease progression as well as identify crucial targets of therapeutic relevance and optimal time windows for targeted intervention.
约三分之二的溶酶体贮积症(LSD)患者会出现神经学表现,如发育迟缓、癫痫发作或精神问题。为了开发有效的治疗方法,了解这些症状背后的神经病理生理学至关重要。溶酶体贮积究竟如何影响神经元的生物发生和功能仍在研究中,然而最近的研究突出了突触缺陷所起的重要作用,如突触棘、突触蛋白、突触后致密物和突触小泡的改变,这些可能导致突触传递功能障碍和神经退行性变,最终导致大量神经元死亡和认知症状的出现。因此,揭示神经学LSD中突触成分是如何受到影响的,将有助于更好地理解疾病进展的复杂性,并确定具有治疗相关性的关键靶点以及靶向干预的最佳时间窗。